SGLT2 Inhibitor Carry-Over Benefits Last How Long? Trial follow-up defines the need for long-term treatment in protecting the kidneys and heart Oct 29, 2024
Kidney Disease Genetic Risk Common in West Africans Observational study points to genetic risk allele dose-response Oct 29, 2024
ľֱ Transplant Trouble Spelled Out for Newer Rejection Episode Categories Study details an intermediate prognosis with newer microvascular inflammation phenotypes Oct 25, 2024
Stroke Prevention Guideline Adds Recs for GLP-1 Drugs, Gender-Affirming Care Recommendation updates also address social determinants of health Oct 21, 2024
Primary Prevention in Hypercholesterolemia Risk prediction tools, risk enhancing factors, and the impact of lifestyle Sep 30, 2024
For Your Patients: Daily Choices That Help Tackle Hypercholesterolemia Lifestyle strategies can help bring cholesterol under control Sep 30, 2024
Medicaid Might Cut Cardiovascular Risk for This One Group Negative results overall hid a benefit for some who won the insurance lottery in Oregon Sep 24, 2024
High-Intensity Noninvasive Ventilation May Reduce Intubation for COPD Exacerbation However, treatment group crossovers muddied the waters in open-label Chinese trial Sep 16, 2024
For Your Patients: How Is Alzheimer's Disease Diagnosed? The care team typically relies on a combination of symptoms and rule-out tests Sep 16, 2024
The Complex Pathogenesis and Genetics of Alzheimer's Disease Amyloid-beta and tau are just one part Sep 16, 2024